Obviousness-Type Double Patenting, PTA, and PTEs: Defeating ODP Rejections, Avoiding Terminal Disclaimers, Impact of In re Cellect

On October 16, 2023, Marbury Senior Partner Tom Irving and Partner Michelle O'Brien will be presenting a webinar on Obviousness-Type Double Patenting and discussing the Federal Circuit's In re Cellect decision.  In Cellect, the CAFC found that ODP was to be evaluated after PTA is added on to patent term, potentially impacting whether a patent [...]

2023-10-12T17:05:40-05:00October 12, 2023|Firm News|

ACI’s Hatch-Waxman and BPCIA Proficiency Series

Marbury Senior Partner Tom Irving will be speaking at ACI’s Hatch-Waxman and BPCIA Proficiency Series, a virtual three-week program designed to provide new lawyers and executives for the life sciences industry with a solid foundation for understanding the essentials as well as the intricacies of Hatch-Waxman and BPCIA litigation and regulation.  The program runs from [...]

2023-10-12T17:01:44-05:00October 12, 2023|Firm News|
Go to Top